
Resources for patients
For help understanding clinical trial listings and for other resources, visit the Patient Resources section.
Clinical Trials
Merck & Co, Inc, Rahway, NJ, USA, known as MSD outside of the United States and Canada, provides international versions of this site for both healthcare professionals and the general public.
Select a language below to be redirected to the MSD version of the site in your chosen language.
Latin America
Europe
Asia Pacific
Australia
Africa

Liver and Bile Duct
When cancer is found in the liver, it most often has its origin from another place in the body, such as the lung or breast. In those cases, it’s called a secondary liver cancer.
Cancer that truly begins in the liver is called a primary liver cancer. Hepatocellular carcinoma (HCC) is the most common primary liver cancer in adults.
This type of liver cancer occurs most often in people with diseases like cirrhosis. Other risk factors include chronic infection with hepatitis B or C. HCC can begin as a solitary tumour that grows and later spreads to other parts of the liver. Or, it can start as many small cancer nodules that spread through the liver. This is more often found in people with cirrhosis.
There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Below is a list of all available liver and bile duct cancer clinical trials. You can narrow the results by choosing options in the dropdown menus below. You can also sort results to show trials nearest to you by entering your city or postal code in the search field.

For help understanding clinical trial listings and for other resources, visit the Patient Resources section.

Learn what clinical trials are, how they work, and if you may be eligible to participate.